DXL Board Formally Asks Stockholders to Vote AGAINST FullBeauty Merger, FOR Reverse Split

summarizeSummary

DXL's board formally asks stockholders to vote against the FullBeauty merger it is contractually obligated to submit, while seeking approval for a reverse stock split and equity plan increase to preserve Nasdaq listing.

check_boxKey Events · M&A and Partnerships · DXLG

• Board Recommends AGAINST Own Merger

  DXL Board unanimously recommends stockholders vote AGAINST the issuance proposal for the FullBeauty Brands merger, citing FBB's potential negative equity value, increased indebtedness, and substantial economic dilution to DXL stockholders.

• Reverse Stock Split Proposed

  Stockholders asked to approve a 1-for-2 to 1-for-30 reverse split to regain Nasdaq's $1.00 minimum bid price compliance; compliance deadline is February 1, 2027.

• 2016 Plan Expansion (9.3% Dilution)

  Proposal to add 13,500,000 shares to the 2016 incentive plan, representing approximately 9.3% dilution if all granted as options; board says reserve is depleted and needed for retention.

• Private Placement Upsized to $107M

  FBB's private placement increased from $92M to $107M via an additional $15M debt-for-equity conversion by Charlesbank and Deutsche Bank affiliates, but FBB's total indebtedness remains substantially higher than anticipated at signing.

auto_awesomeAnalysis · DXLG · Trade & Services

Destination XL's board has formally put the FullBeauty Brands merger to a stockholder vote while simultaneously recommending a vote AGAINST it — an extraordinary governance situation. The proxy statement reveals the board now believes FBB may have negative equity value, that the merger would be 'significantly economically dilutive' to DXL stockholders, and that FBB's indebtedness has increased substantially since the December 2025 agreement. The board is contractually obligated to hold the vote despite its own opposition. Stockholders are also being asked to approve a 1-for-2 to 1-for-30 reverse stock split to regain Nasdaq compliance (minimum $1.00 bid price, deadline February 1, 2027) and a 13.5M share increase to the 2016 incentive plan (9.3% dilution). The private placement backing the merger was upsized from $92M to $107M via an additional $15M debt-for-equity conversion, but FBB's overall debt remains substantially higher than anticipated. The Zodiac tender offer expired August 21 with no shares purchased. This filing crystallizes a board fighting its own merger agreement while simultaneously trying to save the company's Nasdaq listing.